The Venture Codex Logo

The Venture Codex

adMare BioInnovations

2405 Wesbrook Mall, 4th Floor, Vancouver, BC, V6T 1Z3, Canada

Overview

Global life sciences venture building Canadian innovations.

Founded

2019

Deals · 12mo

2

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series A
Series B

Geographic focus

Canada
France
United Kingdom

Sector focus

—

Investment portfolio

7rounds
NAMEDATESIZE
Kainova Therapeutics
Feb 2026Participated
$24 MSeries B
Find Therapeutics
Jan 2026Participated
$7 MSeries A
Epitopea
Oct 2024Participated
$31 MSeries A
Abdera Therapeutics
Apr 2023Participated
$142 MSeries A
Inversago Pharma
Oct 2022Participated
$69 MSeries C
Domain Therapeutics
May 2022Participated
$41 MSeries A
Inversago Pharma
Sep 2020Participated
$38 MSeries B
Kainova Therapeutics
Feb 2026Participated
$24 MSeries B
Find Therapeutics
Jan 2026Participated
$7 MSeries A
Epitopea
Oct 2024Participated
$31 MSeries A
Abdera Therapeutics
Apr 2023Participated
$142 MSeries A
Inversago Pharma
Oct 2022Participated
$69 MSeries C
Domain Therapeutics
May 2022Participated
$41 MSeries A
Inversago Pharma
Sep 2020Participated
$38 MSeries B
7
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

adMare BioInnovations: 7 funding rounds are recorded in the selected participation categories.All available history.
adMare BioInnovations: 7 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A04
Series B02
Series C+01

Monthly Deal Activity

adMare BioInnovations: 7 deals are recorded across 74 months.All available history.
adMare BioInnovations: 7 deals are recorded across 74 months. All available history
MonthDeals
Sep '201
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '221
Jun '220
Jul '220
Aug '220
Sep '220
Oct '221
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '231
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '241
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '261
Feb '261
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

adMare BioInnovations: Health & Life Sciences is the largest displayed sector by deal count (7 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

adMare BioInnovations: Health & Life Sciences is the largest displayed sector by deal count (7 deals). All available history
SectorDeals
Health & Life Sciences7

Deal Size Distribution

adMare BioInnovations: 7 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

adMare BioInnovations: 7 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M1
$25M-$50M3
$50M-$100M1
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

adMare BioInnovations: Canada has the largest recorded deal count among the displayed regions (4 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

adMare BioInnovations: Canada has the largest recorded deal count among the displayed regions (4 deals). All available history
RegionDeals
Canada4
Europe3
adMare BioInnovations: 20 co-investors are shown, with CTI Life Sciences Fund sharing 4 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

adMare BioInnovations: 20 co-investors are shown, with CTI Life Sciences Fund sharing 4 recorded deals. All available history
Co-investorShared deals
CTI Life Sciences Fund4
Fonds de solidarit FTQ3
Investissement Québec3
3B Future Health Fund2
AmorChem2
Forbion2
Panacea Venture2
Schroders Capital2
Seventure Partners2
Turenne Capital2
Viva BioInnovator2
AbCellera1
Advent Life Sciences1
Amgen Ventures1
Amplitude Ventures1
Anges Québec Capital1
Cambridge Innovation Capital1
Genesys1
Genesys Capital1
Harrington Discovery Institute1

Investment Strategy

adMare BioInnovations: Led accounts for 0% and participating for 100% of round participation.All available history.
adMare BioInnovations: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating7100%
adMare BioInnovations: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
adMare BioInnovations: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Gordon McCauley

President & CEO

Lana Janes

Venture Partner